A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma

Manfred Westphal, Oliver Heese, Joachim P. Steinbach, Oliver Schnell, Gabriele Schackert, H. Maximilian Mehdorn, D. Schulz, Matthias Simon, Uwe Schlegel, Christian Senft,

European Journal of Cancer · 2015 · 203 citations · 27 references

Concepts

References

27